Open Peer Review Reports for: A phase II trial comparing pazopanib with doxorubicin as first-line treatment in elderly patients with metastatic or advanced soft tissue sarcoma (EPAZ): study protocol for a randomized controlled trial
Pre-publication versions of this article are available by contacting editorial@trialsjournal.com.
| Original Submission | ||
|---|---|---|
| 28 Oct 2015 | Submitted | Original manuscript |
| 19 Jan 2016 | Reviewed | Reviewer Report - Catherine D'Este |
| 26 Apr 2016 | Reviewed | Reviewer Report - Everardo Saad |
| 26 May 2016 | Author responded | Author comments - Annika Karch |
| Resubmission - Version 2 | ||
| 26 May 2016 | Submitted | Manuscript version 2 |
| 2 Jun 2016 | Reviewed | Reviewer Report - Catherine D'Este |
| Resubmission - Version 3 | ||
| Submitted | Manuscript version 3 | |
| Publishing | ||
| 7 Jun 2016 | Editorially accepted | |
| 7 Jul 2016 | Article published | 10.1186/s13063-016-1434-x |
How does Open Peer Review work?
Open peer review is a system where authors know who the reviewers are, and the reviewers know who the authors are. If the manuscript is accepted, the named reviewer reports are published alongside the article. Pre-publication versions of the article are available by contacting info@biomedcentral.com.
You can find further information about the peer review system here.
